$IRTC
iRhythm Technologies Inc Stock $irtc

$irtc Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000138865822000065 Filed on May 06, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$92.38M	$74.31M
YoY Change	24.31%	16.96%
Cost Of Revenue	$30.62M	$23.46M
YoY Change	30.53%	46.04%
Gross Profit	$61.76M	$50.85M
YoY Change	21.45%	7.12%
Gross Profit Margin	66.85%	68.43%
Selling, General & Admin	$73.16M	$69.81M
YoY Change	4.79%	44.75%
% of Gross Profit	118.46%	137.28%
Research & Development	$10.54M	$8.510M
YoY Change	23.88%	1.13%
% of Gross Profit	17.07%	16.73%
Depreciation & Amortization	$3.143M	$2.040M
YoY Change	54.07%	31.61%
% of Gross Profit	5.09%	4.01%
Operating Expenses	$110.3M	$78.32M
YoY Change	40.84%	38.27%
Operating Profit	-$48.55M	-$27.47M
YoY Change	76.73%	199.47%
Interest Expense	$2.029M	$335.0K
YoY Change	505.67%	-11.84%
% of Operating Profit
Other Income/Expense, Net	$16.00K	$124.0K
YoY Change	-87.1%	-75.45%
Pretax Income	-$50.56M	-$27.68M
YoY Change	82.66%	205.94%
Income Tax	$47.00K	$98.00K
% Of Pretax Income
Net Earnings	-$50.61M	-$27.78M
YoY Change	82.18%	206.44%
Net Earnings / Revenue	-54.78%	-37.38%
Basic Earnings Per Share	-$1.71	-$0.95
Diluted Earnings Per Share	-$1.71	-$0.95
COMMON SHARES
Basic Shares Outstanding	29.60M shares	29.16M shares
Diluted Shares Outstanding	29.60M shares	29.16M shares

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$208.8M	$262.3M
YoY Change	-20.4%	115.39%
Cash & Equivalents	$94.79M	$137.4M
Short-Term Investments	$114.0M	$124.9M
Other Short-Term Assets	$9.838M	$7.000M
YoY Change	40.54%	66.67%
Inventory	$12.45M	$6.863M
Prepaid Expenses
Receivables	$55.29M	$59.98M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$286.4M	$336.1M
YoY Change	-14.8%	117.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$57.14M	$37.45M
YoY Change	52.58%	31.61%
Goodwill	$862.0K	$862.0K
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$19.11M	$14.87M
YoY Change	28.55%	49.5%
Total Long-Term Assets	$142.4M	$142.4M
YoY Change	-0.01%	10.79%
TOTAL ASSETS
Total Short-Term Assets	$286.4M	$336.1M
Total Long-Term Assets	$142.4M	$142.4M
Total Assets	$428.7M	$478.5M
YoY Change	-10.4%	69.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.413M	$5.152M
YoY Change	5.07%	-7.07%
Accrued Expenses	$41.94M	$36.26M
YoY Change	15.65%	55.98%
Deferred Revenue	$2.933M	$1.425M
YoY Change	105.82%	27.8%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$11.70M
YoY Change	-100.0%	138.78%
Total Short-Term Liabilities	$61.78M	$59.38M
YoY Change	4.04%	38.6%
LONG-TERM LIABILITIES
Long-Term Debt	$34.92M	$18.43M
YoY Change	89.49%	-38.73%
Other Long-Term Liabilities	$832.0K	$1.836M
YoY Change	-54.68%	-97.84%
Total Long-Term Liabilities	$35.75M	$20.26M
YoY Change	76.43%	-32.63%
TOTAL LIABILITIES
Total Short-Term Liabilities	$61.78M	$59.38M
Total Long-Term Liabilities	$35.75M	$20.26M
Total Liabilities	$183.9M	$168.9M
YoY Change	8.86%	6.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$456.7M	-$332.5M
YoY Change	37.35%	23.17%
Common Stock	$701.8M	$642.0M
YoY Change	9.32%	62.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$244.8M	$309.6M
YoY Change
Total Liabilities & Shareholders Equity	$428.7M	$478.5M
YoY Change	-10.4%	69.11%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$50.61M	-$27.78M
YoY Change	82.18%	206.44%
Depreciation, Depletion And Amortization	$3.143M	$2.040M
YoY Change	54.07%	31.61%
Cash From Operating Activities	-$38.89M	-$41.84M
YoY Change	-7.07%	87.08%
INVESTING ACTIVITIES
Capital Expenditures	$5.572M	$4.211M
YoY Change	32.32%	23.67%
Acquisitions
YoY Change
Other Investing Activities	-$2.955M	$121.3M
YoY Change	-102.44%	91.49%
Cash From Investing Activities	-$8.527M	$117.0M
YoY Change	-107.29%	95.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.576M
YoY Change		-46.92%
Debt Paid & Issued, Net	$21.39M	$2.917M
YoY Change	633.25%
Cash From Financing Activities	$14.64M	-$26.45M
YoY Change	-155.34%	1671.33%
NET CHANGE
Cash From Operating Activities	-$38.89M	-$41.84M
Cash From Investing Activities	-$8.527M	$117.0M
Cash From Financing Activities	$14.64M	-$26.45M
Net Change In Cash	-$32.78M	$48.75M
YoY Change	-167.24%	35.21%
FREE CASH FLOW
Cash From Operating Activities	-$38.89M	-$41.84M
Capital Expenditures	$5.572M	$4.211M
Free Cash Flow	-$44.46M	-$46.05M
YoY Change	-3.47%	78.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001388658
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	001-37918
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	iRhythm Technologies, Inc.
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-8149544
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	699 8th Street Suite 600
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco,
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94103
CY2022Q1	dei	City Area Code CityAreaCode	415
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	632-5700
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29790161	shares
CY2022Q1	dei	Security12b Title Security12bTitle	Common Stock, Par Value $.001 Per Share
CY2022Q1	dei	Trading Symbol TradingSymbol	IRTC
CY2022Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	94786000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	127562000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	113998000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	111569000	USD
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	55286000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	46430000	USD
CY2022Q1	us-gaap	Inventory Net InventoryNet	12446000	USD
CY2021Q4	us-gaap	Inventory Net InventoryNet	10268000	USD
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9838000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9693000	USD
CY2022Q1	us-gaap	Assets Current AssetsCurrent	286354000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	305522000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57135000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55944000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	65256000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	84587000	USD
CY2022Q1	us-gaap	Goodwill Goodwill	862000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	862000	USD
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19110000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16052000	USD
CY2022Q1	us-gaap	Assets Assets	428717000	USD
CY2021Q4	us-gaap	Assets Assets	462967000	USD
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5413000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	10509000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41935000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51486000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	2933000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3049000	USD
CY2022Q1	us-gaap	Debt Current DebtCurrent	0	USD
CY2021Q4	us-gaap	Debt Current DebtCurrent	11667000	USD
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11501000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11142000	USD
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	61782000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87853000	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34917000	USD
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9690000	USD
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	832000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	697000	USD
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	86344000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	85212000	USD
CY2022Q1	us-gaap	Liabilities Liabilities	183875000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	183452000	USD
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29768718	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29768718	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29493726	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	27000	USD
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29493726	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	27000	USD
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	701822000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	685594000	USD
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-353000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-61000	USD
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-456654000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-406045000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	244842000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	279515000	USD
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	428717000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	462967000	USD
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92378000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74311000	USD
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	30619000	USD
CY2021Q1	us-gaap	Cost Of Revenue CostOfRevenue	23458000	USD
CY2022Q1	us-gaap	Gross Profit GrossProfit	61759000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	50853000	USD
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10542000	USD
CY2021Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	8510000	USD
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	73158000	USD
CY2021Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	69813000	USD
CY2022Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	26608000	USD
CY2021Q1	us-gaap	Restructuring Costs And Asset Impairment Charges RestructuringCostsAndAssetImpairmentCharges	0	USD
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	110308000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	78323000	USD
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-48549000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-27470000	USD
CY2022Q1	us-gaap	Interest Expense InterestExpense	2029000	USD
CY2021Q1	us-gaap	Interest Expense InterestExpense	335000	USD
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	16000	USD
CY2021Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	124000	USD
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-50562000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-27681000	USD
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	98000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-50609000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-27779000	USD
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.71
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.71
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29596325	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29596325	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29164430	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29164430	shares
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-50609000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-27779000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-292000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000	USD
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-50901000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27778000	USD
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-50609000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-27779000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3143000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2036000	USD
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	13903000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	20230000	USD
CY2022Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-432000	USD
CY2021Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-498000	USD
CY2022Q1	irtc	Provision For Doubtful Accounts And Contractual Allowances ProvisionForDoubtfulAccountsAndContractualAllowances	14022000	USD
CY2021Q1	irtc	Provision For Doubtful Accounts And Contractual Allowances ProvisionForDoubtfulAccountsAndContractualAllowances	9768000	USD
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6547000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1555000	USD
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23164000	USD
CY2021Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	22878000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	39818000	USD
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2377000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1608000	USD
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	146000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-387000	USD
CY2022Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3058000	USD
CY2021Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	775000	USD
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5308000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	673000	USD
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-9429000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-6140000	USD
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-116000	USD
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	495000	USD
CY2022Q1	irtc	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-6175000	USD
CY2021Q1	irtc	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1364000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38885000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-41842000	USD
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5572000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4211000	USD
CY2022Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	45974000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	30054000	USD
CY2022Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	15019000	USD
CY2021Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	USD
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	28000000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	151300000	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8527000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	117035000	USD
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	21389000	USD
CY2021Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	2917000	USD
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	35000000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	USD
CY2022Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1076000	USD
CY2021Q1	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	1576000	USD
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	25105000	USD
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	51000	USD
CY2021Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14636000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26446000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-32776000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	48747000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	127562000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88628000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94786000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	137375000	USD
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1967000	USD
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	331000	USD
CY2022Q1	irtc	Property Plant And Equipment Costs Included In Liabilities PropertyPlantAndEquipmentCostsIncludedInLiabilities	225000	USD
CY2021Q1	irtc	Property Plant And Equipment Costs Included In Liabilities PropertyPlantAndEquipmentCostsIncludedInLiabilities	115000	USD
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7666000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5757000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1250000	USD
CY2021Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	911000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	341612000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1576000	USD
CY2021Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	25105000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	19267000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-27779000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	1000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	309572000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	279515000	USD
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1076000	USD
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15152000	USD
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-50609000	USD
CY2022Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-292000	USD
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	244842000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74311000	USD
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contractual allowances, allowance for doubtful accounts, the useful lives of property and equipment, the recoverability of long-lived assets including the estimated usage of the printed circuit board assemblies (“PCBAs”), the incremental borrowing rate for operating leases, accounting for income taxes, impairment of right-of-use assets ("ROU assets"), and various inputs used in estimating stock-based compensation. Certain of these estimates are impacted by uncertainties surrounding COVID-19 such as revenue recognition, contractual allowances for revenue, allowance for doubtful accounts, and stock-based compensation. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that management believes are reasonable under the circumstances, including assumptions as to future events. Actual results may differ from those estimates.</span></div>
CY2022Q1	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	23200000	USD
CY2022Q1	irtc	Uncollected Claims UncollectedClaims	12900000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14012000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12711000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12711000	USD
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4413000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	9615000	USD
CY2021Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3095000	USD
CY2022Q1	irtc	Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments	60000	USD
CY2021	irtc	Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments	8314000	USD
CY2021Q1	irtc	Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments	3046000	USD
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	18365000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14012000	USD
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	12760000	USD
CY2021Q4	irtc	Accounts Receivable For Contractual Allowance AccountsReceivableForContractualAllowance	31274000	USD
CY2020Q4	irtc	Accounts Receivable For Contractual Allowance AccountsReceivableForContractualAllowance	21281000	USD
CY2020Q4	irtc	Accounts Receivable For Contractual Allowance AccountsReceivableForContractualAllowance	21281000	USD
CY2022Q1	irtc	Accounts Receivable Allowance For Contractual Adjustments AccountsReceivableAllowanceForContractualAdjustments	9609000	USD
CY2022Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2700000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	900000	USD
CY2021	irtc	Accounts Receivable Allowance For Contractual Adjustments AccountsReceivableAllowanceForContractualAdjustments	27459000	USD
CY2021Q1	irtc	Accounts Receivable Allowance For Contractual Adjustments AccountsReceivableAllowanceForContractualAdjustments	6673000	USD
CY2022Q1	irtc	Accounts Receivable Contractual Adjustments AccountsReceivableContractualAdjustments	26000	USD
CY2021	irtc	Accounts Receivable Contractual Adjustments AccountsReceivableContractualAdjustments	17466000	USD
CY2021Q1	irtc	Accounts Receivable Contractual Adjustments AccountsReceivableContractualAdjustments	3185000	USD
CY2022Q1	irtc	Accounts Receivable For Contractual Allowance AccountsReceivableForContractualAllowance	40857000	USD
CY2021Q4	irtc	Accounts Receivable For Contractual Allowance AccountsReceivableForContractualAllowance	31274000	USD
CY2021Q1	irtc	Accounts Receivable For Contractual Allowance AccountsReceivableForContractualAllowance	24769000	USD
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:18pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Risk</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Risk</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, investments and accounts receivable. Cash balances are deposited in financial institutions which, at times may be in excess of federally insured limits. Cash equivalents are invested in highly-rated money market funds. The Company invests in a variety of financial instruments, such as but not limited to, U.S. government securities, corporate notes, commercial paper and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments.</span></div>Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers comprising the Company’s customer base and their dispersion across many geographies. The Company does not require collateral. The Company records an allowance for doubtful accounts based on the assessment of the collectability of customer accounts, considering factors such as historical experience, credit quality, the age of the accounts receivable balances, and current economic conditions that may affect a customer’s ability to pay.
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	92378000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	156940000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	5000	USD
CY2022Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	358000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	156587000	USD
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	42589000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	113998000	USD
CY2022Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	156587000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	221767000	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2021Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	61000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	221706000	USD
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	110137000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	111569000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	221706000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	156587000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	221706000	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	0	USD
CY2022Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	156587000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	221706000	USD
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment_security
CY2022Q1	irtc	Available For Sale Debt Securities Maturity Period AvailableForSaleDebtSecuritiesMaturityPeriod	P111D
CY2022Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	11	investment_security
CY2022Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	0	investment_security
CY2022Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	156587000	USD
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	221706000	USD
CY2022Q1	irtc	Inventory And Printed Circuit Board Assemblies InventoryAndPrintedCircuitBoardAssemblies	12446000	USD
CY2021Q4	irtc	Inventory And Printed Circuit Board Assemblies InventoryAndPrintedCircuitBoardAssemblies	10268000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	82981000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	78648000	USD
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25846000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22704000	USD
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	57135000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	55944000	USD
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3100000	USD
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2000000.0	USD
CY2022Q1	us-gaap	Accrued Vacation Current AccruedVacationCurrent	8371000	USD
CY2021Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	7431000	USD
CY2022Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	18871000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	34484000	USD
CY2022Q1	irtc	Accrued Employee Stock Purchase Plan Contribution AccruedEmployeeStockPurchasePlanContribution	2748000	USD
CY2021Q4	irtc	Accrued Employee Stock Purchase Plan Contribution AccruedEmployeeStockPurchasePlanContribution	1002000	USD
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1794000	USD
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1724000	USD
CY2022Q1	us-gaap	Interest Payable Current InterestPayableCurrent	47000	USD
CY2021Q4	us-gaap	Interest Payable Current InterestPayableCurrent	78000	USD
CY2022Q1	irtc	Claims Payable Current ClaimsPayableCurrent	2770000	USD
CY2021Q4	irtc	Claims Payable Current ClaimsPayableCurrent	2988000	USD
CY2022Q1	us-gaap	Restructuring Reserve RestructuringReserve	2902000	USD
CY2021Q4	us-gaap	Restructuring Reserve RestructuringReserve	0	USD
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4432000	USD
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	3779000	USD
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41935000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51486000	USD
CY2022Q1	irtc	Sublease Square Feet Percent SubleaseSquareFeetPercent	0.50
CY2022Q1	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23164000	USD
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	3400000	USD
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3200000	USD
CY2022Q1	irtc	Lessee Operating Sublease Lease Percentage LesseeOperatingSubleaseLeasePercentage	0.50
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	6550000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	13995000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14265000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	14681000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	15108000	USD
CY2022Q1	irtc	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	75390000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	139989000	USD
CY2022Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	42144000	USD
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	97845000	USD
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y6M21D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	7.28
CY2022Q1	irtc	Collaboration Agreement Additional Milestone Payments Between2022 And Early2023 CollaborationAgreementAdditionalMilestonePaymentsBetween2022AndEarly2023	1750000	USD
CY2022Q1	irtc	Collaboration Agreement Milestone Payments CollaborationAgreementMilestonePayments	0	USD
CY2022Q1	us-gaap	Dividends Common Stock DividendsCommonStock	0	USD
CY2022Q1	us-gaap	Debt Current DebtCurrent	0	USD
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	34917000	USD
CY2022Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	34917000	USD
CY2022Q1	irtc	Operating Loss Carryforwards Tax Benefit Recognized OperatingLossCarryforwardsTaxBenefitRecognized	0	USD
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	12805857	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	11164880	shares
CY2022Q1	irtc	Stock Issued During Period Shares Restricted Stock Award Grants In Period StockIssuedDuringPeriodSharesRestrictedStockAwardGrantsInPeriod	129	shares
CY2022Q1	irtc	Stock Issued During Period Shares Restricted Stock Award Vested StockIssuedDuringPeriodSharesRestrictedStockAwardVested	206006	shares
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	55860	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	609881	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.18
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M26D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	120163000	USD
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	90939	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	31.15
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	14836	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	68.81
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	504106	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.97
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M12D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	38675000	USD
CY2022Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	22114	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	48.63
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1228	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	84.54
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	480764	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40.51
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y7D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	56232000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	475910	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	40.06
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y11M26D
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	55876000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	480687	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	40.50
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y7D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	56227000	USD
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0	shares
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13903000	USD
CY2021Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20230000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	300000	USD
CY2022Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y7M6D
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-50609000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-27779000	USD
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29596325	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29596325	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29164430	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29164430	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.71
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.71
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.95
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.95
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2197984	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1765487	shares

Files In Submission

Name	View Source	Status
0001388658-22-000065-index-headers.html	Edgar Link	pending
0001388658-22-000065-index.html	Edgar Link	pending
0001388658-22-000065.txt	Edgar Link	pending
0001388658-22-000065-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
irtc-20220331.htm	Edgar Link	pending
irtc-20220331.xsd	Edgar Link	pending
irtc-20220331xex311.htm	Edgar Link	pending
irtc-20220331xex312.htm	Edgar Link	pending
irtc-20220331xex321.htm	Edgar Link	pending
irtc-20220331_cal.xml	Edgar Link	unprocessable
irtc-20220331_def.xml	Edgar Link	unprocessable
irtc-20220331_htm.xml	Edgar Link	completed
irtc-20220331_lab.xml	Edgar Link	unprocessable
irtc-20220331_pre.xml	Edgar Link	unprocessable
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IRTC
iRhythm Technologies Inc Stock $irtc

2022 Q1 Form 10-Q Financial Statement

#000138865822000065 Filed on May 06, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRTC iRhythm Technologies Inc Stock $irtc

2022 Q1 Form 10-Q Financial Statement

#000138865822000065 Filed on May 06, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IRTC
iRhythm Technologies Inc Stock $irtc